Rubicon Research Approves Grant of 68,982 Stock Options Under ESOP 2026
Rubicon Research Ltd 路 Others (Uncategorized) 路 05 Nov 2026, 2:41 pm
Rubicon Research Approves Grant of 68,982 Stock Options Under ESOP 2026 Rubicon Research Limited's Nomination and Remuneration Committee approved the grant of up to 68,982 stock options under the Rubicon Research Limited Stock Option Plan 2026 on 4th Nov'26. The options cover up to 68,982 equity shares of face value Re. 1 each at an exercise price of Rs. 1,374.40 per share. The scheme complies with SEBI (SBEB) Regulations, 2021, featuring a vesting period of up to 5 years from the grant date and an exercise period of 5 years from vesting.
Original exchange filing (PDF)
More announcements from Rubicon Research Ltd
- Disclosure under Regulation 30 of SEBI LODR Regulations, 2015 (SEBI Regulations) w.r.t update on the Scheme of Merger between Rubicon Research Ltd and KIA Health Tech Pvt Ltd 路 14 Nov 2026
- Transcript of Earnings Call -Q2 - FY 2026-27 路 12 Nov 2026
- Audio Recording of Earnings confrence call for the Quarter ended 30th September, 2026 路 06 Nov 2026
- Monitoring Agency Report - Q2 ended September 2026 路 05 Nov 2026
- Investor Presentation for Q2 2026-27 路 05 Nov 2026
- Rubicon Research Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Outcome of the Board Meeting held on November 5, 2026 路 05 Nov 2026
- Outcome of USFDA Inspection of Rubicon Research Ltd Manufactiring Facility at Ambernath, India 路 30 Oct 2026
